InvestorsHub Logo
Followers 17
Posts 1224
Boards Moderated 1
Alias Born 06/30/2014

Re: None

Wednesday, 11/25/2020 11:33:35 AM

Wednesday, November 25, 2020 11:33:35 AM

Post# of 4160
Lakersback: Once FTA granted, the next steps are for the TMO to get 4-5 clinical site open to enroll and treat patients in U.S. Which was outlined the Q3 newsletter.

11.25.20 Per Stockhouse (V.TLT Bullboard)member FloatinKentucky: Theralase® is in advanced discussions to launch a number of U.S. based clinical study sites in 4Q2020, subject to the United States economy recovering from the COVID-19 pandemic. The U.S. based Trial Management Organization (“TMO”) plans to launch 4 to 5 clinical study sites in 4Q2020 and commence Study II patient enrollment and treatment as early as 1Q2021

3Q2020 QUARTERLY NEWSLETTER

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=31969591

I'd say that pretty much sums it up.

Good luck to all. Regards,BK.